Swiss National Bank Mirum Pharmaceuticals, Inc. Transaction History
Swiss National Bank
- $146 Billion
- Q4 2024
A detailed history of Swiss National Bank transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 70,300 shares of MIRM stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,300
Previous 69,000
1.88%
Holding current value
$3.57 Million
Previous $2.69 Million
7.99%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
200Shares Held
54.6MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$333 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$227 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$175 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$164 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$156 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.86B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...